Science news articles about 'sudhir paul'

... FVIII and negate its blood-clotting benefits. To combat this problem, scientists in the laboratory of Sudhir Paul, Ph.D., at The University of Texas Medical School at Houston, developed a chemically ...

... under study as a target for therapeutic intervention. Sudhir Paul, Ph.D., pathology professor ... HIV effect is weaker. "The work of Dr. Paul's group is highly innovative. They have identified antibodies ...

... HIV vaccine. Our findings open a new path toward an effective preventative and therapeutic vaccine," said Sudhir Paul, Ph.D., the study's senior author and a professor in the Department of Pathology ...